Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
First Trust Indxx Medical Devices ETF (MDEV) belongs to the Healthcare Technology segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. MDEV is more expensive with a Total Expense Ratio (TER) of 0.7%, versus 0.54% for FBT. MDEV is down -9.65% year-to-date (YTD) with - in YTD flows. FBT performs better with -5.96% YTD performance, and +$1.10B in YTD flows. Run a side-by-side ETF comparison of MDEV and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MDEV FBT | -7.17%-5.58% | -10.08%-7.34% | -9.65%-5.96% | -5.78%+15.04% | -1.29%+29.35% | n/a+20.07% |
| Flows | MDEV FBT | -+$11M | -+$1.10B | -+$1.10B | +$0K+$1.09B | -$228K+$639M | -+$246M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MDEV FBT | +13.97%+22.00% | +18.29%+24.20% | +15.82%+19.85% | n/a+21.81% |
| Max drawdown | MDEV FBT | -13.00%-12.74% | -13.00%-14.81% | -23.75%-19.92% | n/a-29.98% |
| Max drawdown duration | MDEV FBT | 65d49d | 65d148d | 317d237d | n/a1243d |
MDEV | FBT | |
Last sale 3/12/2026 at 4:55 PM | $18.98 | $192.26 |
| Previous close 03/12/2026 | $19.37 | $193.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
MDEV | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
MDEV | FBT | |
|---|---|---|
| Last price | $18.98 | $192.26 |
| 1D performance | -2.01% | -0.68% |
| AuM | $1.90 M | $2.22 B |
| E/R | 0.7% | 0.54% |
MDEV | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | First Trust |
| Benchmark | Indxx Global Medical Equipment Index | NYSE Arca Biotechnology Index |
| N° of holdings | 48 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2021 | June 19, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
